UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
21.07
-0.73 (-3.35%)
Feb 20, 2026, 4:00 PM EST - Market closed
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $986.26 million as of February 20, 2026. Its market cap has increased by 100.79% in one year.
Market Cap
986.26M
Enterprise Value
988.79M
1-Year Change
100.79%
Ranking
Category
Stock Price
$21.07
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $986.26M, an increase of 442.20%. That is a compound annual growth rate of 21.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 986.30M | -10.03% |
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sana Biotechnology | 1.10B |
| Vir Biotechnology | 1.09B |
| Fortrea Holdings | 1.02B |
| Ventyx Biosciences | 1.00B |
| SpyGlass Pharma | 988.86M |
| Theravance Biopharma | 984.57M |
| GH Research | 980.06M |
| Palvella Therapeutics | 974.50M |